- Home
- SGHT vs REFI Comparison
SGHT vs REFI Comparison
Compare SGHT & REFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGHT
- REFI
- Stock Information
- Founded
- SGHT 2011
- REFI 2021
- Country
- SGHT United States
- REFI United States
- Employees
- SGHT N/A
- REFI N/A
- Industry
- SGHT Medical Specialities
- REFI Real Estate Investment Trusts
- Sector
- SGHT Health Care
- REFI Real Estate
- Exchange
- SGHT Nasdaq
- REFI Nasdaq
- Market Cap
- SGHT 304.4M
- REFI 306.1M
- IPO Year
- SGHT 2021
- REFI 2021
- Fundamental
- Price
- SGHT $3.57
- REFI $16.16
- Analyst Decision
- SGHT Buy
- REFI Strong Buy
- Analyst Count
- SGHT 7
- REFI 3
- Target Price
- SGHT $6.27
- REFI $20.00
- AVG Volume (30 Days)
- SGHT 218.9K
- REFI 118.5K
- Earning Date
- SGHT 11-07-2024
- REFI 11-07-2024
- Dividend Yield
- SGHT N/A
- REFI 11.63%
- EPS Growth
- SGHT N/A
- REFI N/A
- EPS
- SGHT N/A
- REFI 2.00
- Revenue
- SGHT $79,543,000.00
- REFI $56,860,278.00
- Revenue This Year
- SGHT $2.13
- REFI N/A
- Revenue Next Year
- SGHT $7.99
- REFI $4.27
- P/E Ratio
- SGHT N/A
- REFI $8.08
- Revenue Growth
- SGHT N/A
- REFI 6.49
- 52 Week Low
- SGHT $3.30
- REFI $14.82
- 52 Week High
- SGHT $8.45
- REFI $17.65
- Technical
- Relative Strength Index (RSI)
- SGHT 39.52
- REFI 56.28
- Support Level
- SGHT $3.45
- REFI $15.69
- Resistance Level
- SGHT $3.64
- REFI $16.24
- Average True Range (ATR)
- SGHT 0.19
- REFI 0.20
- MACD
- SGHT 0.03
- REFI -0.02
- Stochastic Oscillator
- SGHT 31.90
- REFI 79.03
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
About REFI Chicago Atlantic Real Estate Finance Inc.
Chicago Atlantic Real Estate Finance Inc is engaged in a commercial real estate finance company. Its primary investment objective is to provide attractive risk-adjusted returns for stockholders over time, through consistent current income dividends and other distributions and secondarily through capital appreciation.